Morphic Therapeutic

86 articles with Morphic Therapeutic

• 

  AbbVie Invests $100 Million in Morphic Therapeutics to Develop Integrin Inhibitors for Fibrotic D...

  10/18/2018

  Weeks after Waltham, Mass.-based Morphic Therapeutic secured $80 million in Series B financing that was supported in part by AbbVie Ventures, the company struck a deal with the pharma giant to collaborate on the development of therapies for fibrosis-related indications.

• Morphic Therapeutic Announces $80 Million Financing to Advance Next-Generation Oral Integrin Therapeutics Through Clinical Proof of Concept

  9/25/2018

  Series B financing led by Omega Funds and Novo Holdings

• 

  $80 Million Series B Financing Funds Morphic Therapeutic’s Next-Generation Oral Integrin

  9/25/2018

  Biotechnology company Morphic Therapeutic has just publicized their completion of a successful $80 million Series B financing meant to support their two lead programs in developing modern oral integrin therapies, as well as further other clinic programs.

• What You Need to Know About Morphic Therapeutic

  1/19/2017

• 

  The Next Generation: Top 20 Life Science Startups to Watch in 2017

  1/9/2017

  BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.

• With Investments from Pfizer and AbbVie, Morphic Therapeutic Closes a $51.5 Million Series A Round

  7/1/2016